Sepracor-Looks very promising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: M. Ramle who wrote (3787)	10/25/1999 11:17:00 AM
From: rkrw	Read Replies (1) of 10280

<<IMHO, I think that would be very foolish for the Management to even be considering any acquisitions at this time. They (SEPR) are NOT even out of the woods yet, and they need to rack up more interest in their own stock first. Any comments !!!! Thanks and Good Luck.>> M. The xopenex sales force, at least for the moment, is inefficient selling just one product, xopenex nebulizer. Their selling and marketing expenses last quarter were very high. In other words, they are losing money marketing xopenex and may well continue to do so through all of next year. If they can leverage the force against a second or third product, via acquisition, product acquisition, product purchase, quid, whatever, they could achieve greater sales efficiencies and downstream profitability. The alternative is to sit and wait for internally developed follow on products which are approximately 2-3 years away from market. Managements sole pursuit should be maximizing long term shareholder wealth not prioritizing the share price for the next few weeks. If a product acquisition arises that will benefit shareholders I'd hope it would be strongly considered.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next